The Effects of Sevelamer and Calcium Acetate on Proxies of Atherosclerotic and Arteriosclerotic Vascular Disease in Hemodialysis Patients

Publisher： Karger

E-ISSN： 1421-9670|23|5|307-314

ISSN： 0250-8095

Source： American Journal of Nephrology, Vol.23, Iss.5, 2003-09, pp. : 307-314

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paricalcitol Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients on Sevelamer Hydrochloride: Which Dialysate Calcium Concentration to Use?

By  

Blood Purification, Vol. 27, Iss. 2, 2009-01 ,pp. : 182-186

Karger

Access to resources Recommend Favorite

Calcium Acetate/Magnesium Carbonate and Cardiovascular Risk Factors in Chronic Hemodialysis Patients

By  

Nephron, Vol. 132, Iss. 4, 2016-03 ,pp. : 317-326

Karger

Access to resources Recommend Favorite

Treatment with Sevelamer Decreases Bicarbonate Levels in Hemodialysis Patients

By  

Nephron, Vol. 92, Iss. 2, 2002-09 ,pp. : 499-500

Karger

Access to resources Recommend Favorite

Emerging Effects of Sevelamer in Chronic Kidney Disease

By  

Kidney and Blood Pressure Research, Vol. 37, Iss. 1, 2013-03 ,pp. : 24-32

Karger

Access to resources Recommend Favorite

Vascular Calcification in Maintenance Hemodialysis Patients

By  

Blood Purification, Vol. 28, Iss. 1, 2009-03 ,pp. : 15-20

Karger

Access to resources Recommend Favorite